PRESS RELEASE published on 04/25/2025 at 07:00, 11 months 9 days ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report covering the first three months of 2025 revealing a net loss of CHF 241 mn. More information at report.bbbiotech.ch/Q125 Financial Results Investment Company BB Biotech AG Interim Report Business Activities
PRESS RELEASE published on 04/25/2025 at 07:00, 11 months 9 days ago BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility BB Biotech AG reports net loss in Q1 2025 due to market volatility. Portfolio focus on innovative biotech companies above USD 1 bn. Details on exits and regulatory milestones Market Volatility BB Biotech AG Biotech Companies Q1 2025 Portfolio Focus
BRIEF published on 03/19/2025 at 17:50, 1 year ago Les actionnaires de BB Biotech AG approuvent le dividende et réélisent le conseil d'administration Dividende Stratégie D'investissement Réélection Du Conseil D'administration BB Biotech Assemblée Générale Annuelle 2025
BRIEF published on 03/19/2025 at 17:50, 1 year ago BB Biotech AG Shareholders Approve Dividend and Re-Elect Board Investment Strategy Dividend Board Re-election BB Biotech AGM 2025
PRESS RELEASE published on 03/19/2025 at 17:45, 1 year ago Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 1.80 per share Shareholders at BB Biotech AG’s AGM approve dividend of CHF 1.80 per share and all board proposals. Re-elected board members for another term Shareholders Dividend AGM BB Biotech AG Board Proposals
BRIEF published on 02/21/2025 at 07:05, 1 year 1 month ago BB Biotech AG Releases 2024 Annual Report Dividend Proposal Net Profit BB Biotech AG Biotechnology Sector 2024 Annual Report
BRIEF published on 02/21/2025 at 07:05, 1 year 1 month ago BB Biotech AG publie son rapport annuel 2024 Bénéfice Net Proposition De Dividende BB Biotech SA Rapport Annuel 2024 Secteur De La Biotechnologie
BRIEF published on 02/21/2025 at 07:05, 1 year 1 month ago BB Biotech navigue dans la reprise précoce du secteur biotechnologique en 2024 Stratégie D'investissement Résultats Financiers 2024 Biotechnologie BB Reprise De La Biotechnologie Étapes Réglementaires Importantes
BRIEF published on 02/21/2025 at 07:05, 1 year 1 month ago BB Biotech Navigates Biotech Sector's Early Recovery in 2024 Investment Strategy 2024 Financial Performance BB Biotech Regulatory Milestones Biotech Recovery
PRESS RELEASE published on 02/21/2025 at 07:00, 1 year 1 month ago EQS-Adhoc: BB Biotech AG publishes its 2024 annual report BB Biotech AG publishes its 2024 annual report, revealing financial performance and proposed dividend. Report includes biotech sector overview and investment details Biotechnology Investment Dividend BB Biotech AG 2024 Annual Report
Published on 04/02/2026 at 22:00, 1 day 20 hours ago Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 2 days ago Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 2 days 3 hours ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 2 days 4 hours ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 2 days 4 hours ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/04/2026 at 10:07, 8 hours 36 minutes ago Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Published on 04/04/2026 at 02:05, 16 hours 38 minutes ago Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 1 day ago IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 1 day ago IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 1 day ago Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems
Published on 04/03/2026 at 18:46, 23 hours 56 minutes ago Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 23 hours 56 minutes ago Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 1 day ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 1 day ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 1 day ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026
